Areas of interest (AOI) & competitive research grants
We are currently accepting concepts for the following therapeutic areas. BMS periodically opens RFP Cycles across different therapeutic areas and the pre-concept submission periods will be posted below when available. We strongly encourage all applicants to begin the online application process early to allow adequate time for completion. For a submission to qualify for review, all information including any required uploads must be submitted through the application form prior to the specified end dates for the RFP Cycle.
| Therapeutic Area and / or Compound | AOIs Posted on BMS.com | Pre-Concept Submission Period | |
| Start Date | End date | ||
| Cardiovascular – CAMZYOS (Mavacamten) | Feb 23, 2024 | Mar 04, 2024 | Apr 11, 2024 |
| Immunology – Sotyktu (Deucravacitinib) | Feb 26, 2024 | Mar 25, 2024 | Apr 25, 2024 |
| Immunology – Sotyktu (Deucravacitinib) – Dermatology | Aug 26, 2024 | Sept 23, 2024 | Nov 14, 2024 |
| Immunology – Sotyktu (Deucravacitinib) - Rheumatology | Aug 26, 2024 | Sept 23, 2024 | Nov 14, 2024 |
Please note that during an open RFP submission window, clicking on a link to submit your research idea will take you to the FastTrack Investigator Portal and you will receive a message that you are leaving BMS.com. This is part of the normal process.
- If you are a potential investigator who is interested in seeking support to conduct independent research involving Nivolumab in Japan, Taiwan, or Korea, click here
- If you are a potential investigator who is interested in seeking support for independent research using Apixaban, click here.
- If you are a potential investigator who is interested in seeking support for non-clinical research using a BMS product, click here
- If you are a potential investigator who is interested in seeking support for independent research using one of our early pipeline assets, click here